Sun Pharmaceutical Industries reports 13% rise in Q2 consolidated net profit
2nd Nov 2021

Sun Pharmaceutical Industries has reported results for second quarter ended September 30, 2021.

The company has reported over 3-fold jump in its net profit at Rs 809.07 crore for the quarter under review as compared to Rs 223.70 crore for the same quarter in the previous year. Total income of the company increased by 22.49% at Rs 4427.42 crore for Q2FY22 as compared Rs 3614.53 crore for the corresponding quarter previous year.

On the consolidated basis, the company has reported a rise of 12.92% in its net profit at Rs 2047.01 crore for the quarter under review as compared to Rs 1812.79 crore for the same quarter in the previous year. Total income of the company increased by 11.81 % at Rs 9,848.82 crore for Q2FY22 as compared Rs 8808.91 crore for the corresponding quarter previous year.